Duration of serologic response to three viral antigens in cats
Authors:
- Marianne J. LorenzenMLMarianne J. Lorenzen
- John D. HaworthJHJohn D. Haworth
- Vickie L. KingVKVickie L. King
- 1 January 2004
- journal article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 224 (1) , 61-66
Abstract
Objective—To determine whether vaccinated cats either remained seropositive or responded serologically to revaccination against 3 key viral antigens after extended periods since their last vaccination. Design—Serologic survey. Animals—272 healthy client-owned cats. Procedure—Cats were ≥ 2 years old and vaccinated for feline panleukopenia virus (FPV), feline calicivirus (FCV), and feline herpesvirus (FHV). On day 0, cats were revaccinated with a vaccine from the same line of vaccines as they had historically received. Antibody titers were measured in sera collected on day 0 (prevaccination titer) and 5 to 7 days later (postvaccination titer). Cats were considered to have responded serologically if they had a day-0 hemagglutination inhibition titer to FPV ≥ 1:40, serum neutralization (SN) titer to FCV ≥ 1:32, SN titer to FHV ≥ 1:16, or ≥ 4-fold increase in antibody titer after revaccination. Results—The percentage of cats that had titers at or above the threshold values or responded to revaccination with a ≥ 4-fold increase in titer was 96.7% for FPV, 97.8% for FCV, and 88.2% for FHV. Conclusions and Clinical Relevance—In most cats, vaccination induced a response that lasted up to and beyond 48 months for all 3 antigens. Although not equivalent to challenge-of-immunity studies as a demonstration of efficacy, results suggest that revaccination with the vaccine used in our study provides adequate protection even when given less frequently than the traditional 1-year interval. The study provides valuable information for clinicians to determine appropriate revaccination intervals. (J Am Vet Med Assoc 2004;224:61–66)Keywords
This publication has 16 references indexed in Scilit:
- AVMA Council on Biologic and Therapeutic Agents' report on cat and dog vaccinesJournal of the American Veterinary Medical Association, 2002
- Evaluation of antithyroglobulin antibodies after routine vaccination in pet and research dogsJournal of the American Veterinary Medical Association, 2002
- Cost‐effectiveness analysis of the Lyme disease vaccineArthritis & Rheumatism, 2002
- World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in catsJournal of the American Veterinary Medical Association, 2002
- Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in catsJournal of the American Veterinary Medical Association, 2002
- "Endgame" Issues for the Global Polio Eradication InitiativeClinical Infectious Diseases, 2002
- Duration of immunity in dogs after vaccination or naturally acquired infectionVeterinary Record, 2001
- Canine VaccinationVeterinary Clinics of North America: Small Animal Practice, 2001
- Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogsJournal of the American Veterinary Medical Association, 2000
- Canine Viral Vaccines at a Turning Point—A Personal Perspective1999